| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.05 | 0.3 |